Company: SXTPW
Filing Date: 2025-07-16
Form Type: 424B4
Source: 0001213900-25-064472
Chunk: 65

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-07-16
Form: 424B4
Chunk 65
---
 five-year anniversary of commencement of sales in this offering. The other terms of the Placement Agent Warrants
are substantially similar to the terms of the Warrants. The offer and sale of the Placement Agent Warrants, as well as the offer and
sale of the shares of our common stock issuable upon exercise thereof, are registered on the registration statement of which this
prospectus is a part. The form of the Placement Agent Warrants is included as an exhibit to this registration statement of which
this prospectus forms a part.

As previously disclosed,
on each of January 28, 2025 and February 5, 2025, we consummated a registered direct offering and a concurrent private placement of shares
of our common stock and warrants. In connection with the January 28, 2025 offerings, we issued to H.C. Wainwright & Co., LLC, as placement
agent, immediately exercisable warrants to purchase up to 15,325 shares of common stock with an exercise price of $6.382 per share that
expire 24 months from the date of issuance. In connection with the February 5, 2025 offerings, we issued to H.C. Wainwright & Co.,
LLC, as placement agent, immediately exercisable warrants to purchase up to 22,554 shares of common stock with an exercise price of $4.469
per share that expire 24 months from the date of issuance. FINRA has deemed these warrants to be placement agent compensation in connection
with this offering.

Right of First Refusal

We have granted the placement
agent a right of first refusal for a period of twelve (12) months following the closing of this offering to act as sole book-running manager,
sole underwriter or sole placement agent for each and every future public or private offering or other capital-raising financing of equity
or equity-linked securities using an underwriter or placement agent by us or any of our successors or subsidiaries, subject to certain
exceptions.

Tail

We have also agreed to
pay the placement agent a tail fee equal to the cash and warrant compensation in this offering, if any investor, who was wall-crossed
by the placement agent with respect to a non-public offering or had back and forth correspondence with the placement agent with respect
to a public offering of our securities, in each case during the term of its engagement, provides us with capital in any public or private
offering or other financing or capital raising transaction during the twelve-month period following expiration or